Urol. praxi. 2026;27(1):18-22 | DOI: 10.36290/uro.2025.081

Imaging of tumours of the kidney and urinary tract using computed tomography

MUDr. Jan Pernický, Ph.D.1, MUDr. Petr Stránský ml.2, prof. MUDr. Jiří Ferda, Ph.D.1, prof. MUDr. Milan Hora, Ph.D., MBA2
1 Klinika zobrazovacích metod, Fakultní nemocnice Plzeň
2 Urologická klinika, Fakultní nemocnice Plzeň

Computed tomography (CT) is the fundamental imaging technique in diagnosing tumours of the kidney and urinary tract. It enables the detection, characterization, and staging of renal and urothelial cancers and remains the method of choice owing to its high spatial and temporal resolution and wide availability. Multiphase protocols provide detailed information on lesion morphology and enhancement characteristics, including assessment of lymph node involvement and distant metastases. CT urograp­hy is crucial for diagnosing urothelial carcinomas of the upper and lower urinary tracts. The main limitations of CT are the difficult differential diagnosis of some benign and malignant lesions and the limited ability to assess the depth of bladder cancer invasion. The development of spectral techniques and dual-energy testing brings new possibilities, particularly in terms of reducing the radiation burden and improving the quality of the imaging data obtained.

Keywords: imaging techniques, computed tomography, CT urography, renal carcinoma, urothelial carcinoma.

Received: October 7, 2025; Revised: October 23, 2025; Accepted: October 27, 2025; Prepublished online: October 27, 2025; Published: March 16, 2026  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Pernický J, Stránský P, Ferda J, Hora M. Imaging of tumours of the kidney and urinary tract using computed tomography. Urol. praxi. 2026;27(1):18-22. doi: 10.36290/uro.2025.081.
Download citation

References

  1. Bex A, Ghanem YA, Albiges L, et al. European Association of Urology Guidelines on Renal Cell Carcinoma: The 2025 Update. Eur Urol. 2025;87(6):683-696. Go to original source... Go to PubMed...
  2. Ferda J, Vendiš T, Baxa J, et al. Výpočetní tomografie s použitím photon-counting detektoru. Na počest 125. výročí objevení paprsků X Wilhelmem Conradem Röntgenem. Ces radiol. 2020;74(3):159-170. Go to original source...
  3. Ferda J, Kastner J, Ferdová E, et al. Imaging of solid kidney tumors. Ces radiol. 2012;66(3):271-281.
  4. Ferda J, Kastner J, Ferdová E, et al. Staging of the urothelial tumors. Ces radiol. 2012;66(3):282-288.
  5. McNicholas MM, Raptopoulos VD, Schwartz RK, et al. Excretory phase CT urography for opacification of the urinary collecting system. AJR Am J Roentgenol. 1998;170(5):1261-1267. Go to original source... Go to PubMed...
  6. Hora M. Nádory ledvin. Urol. praxi. 2006;6(1):28-30.
  7. Ferda J, Kastner J, Ferdová E, et al. Zobrazení solidních nádorů ledvin. Ces radiol. 2012;66(3):271-281.
  8. Pitra T, Pivovarčíková K, Trávníček I, et al. Cystické tumory ledvin. Ces urol. 2016;20(3):204-213. Go to original source...
  9. Smith CJ, Wang MX, Feely M, et al. Oncocytoma: A Differential Consideration for an Incidentally Detected FDG-Avid Renal Mass on PET/CT. Journal of Radiology Case Reports. 2017;11(5):27-33. Go to original source... Go to PubMed...
  10. Lamla A, Pernička J. Benigní nádory ledvin. Urol. praxi. 2003;4(3):90-93.
  11. Ürge T, Hora M, Hes O, et al. Renální angiomyolipom, histologie, diagnostika a terapie. Urol. praxi. 2006;6(6):270-272.
  12. Belej K, Kaplan O. Možnosti CT a MR v zobrazení nádorů močového měchýře. Urol. praxi. 2007;8(1):15-17.
  13. Karmašová K, Čermák A. Zobrazovací metody, jejich přínos pro zjištění rozsahu onemocnění karcinomem močového měchýře. Urologické listy [online]. 2012 [cited 25. 8. 2025]. Available from: https://is.muni.cz/publication/1082283/cs/Zobrazovaci-metody-jejich-prinos-pro-zjisteni-rozsahu-onemocneni-karcinomem-mocoveho-mechyre/Karmasova-Cermak.
  14. Ngowi BN, Kimolo M, Mbwambo J, et al. Giant intravesical prostatic protrusion mimicking bladder carcinoma: Navigating diagnostic and management challenges. Int J Surg Case Rep. 2024;118:109590. Go to original source... Go to PubMed...
  15. Kőhler O, Belej K. Léčba uroteliálního karcinomu horních močových cest. Urol. praxi. 2012;13(5):204-207.




Urology for Practice

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.